日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

阿伐普利尼治疗晚期系统性肥大细胞增生症的安全性和有效性:1期EXPLORER试验

DeAngelo, Daniel J; Radia, Deepti H; George, Tracy I; Robinson, William A; Quiery, Albert T; Drummond, Mark W; Bose, Prithviraj; Hexner, Elizabeth O; Winton, Elliott F; Horny, Hans-Peter; Tugnait, Meera; Schmidt-Kittler, Oleg; Evans, Erica K; Lin, Hui-Min; Mar, Brenton G; Verstovsek, Srdan; Deininger, Michael W; Gotlib, Jason

Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.

鲁索替尼治疗成人继发性噬血细胞性淋巴组织细胞增生症:一项开放标签、单中心、试点试验

Ahmed Asra, Merrill Samuel A, Alsawah Fares, Bockenstedt Paula, Campagnaro Erica, Devata Sumana, Gitlin Scott D, Kaminski Mark, Cusick Alice, Phillips Tycel, Sood Suman, Talpaz Moshe, Quiery Albert, Boonstra Philip S, Wilcox Ryan A